-

FORM, The Virtual Obesity Medicine Clinic, Announces Two Executive Hires

Danielle Snow Has Joined the Company as Chief Operating Officer;
Matteo Zanella as Vice President of Product

BOSTON--(BUSINESS WIRE)--Today, FORM, the virtual obesity medicine clinic, announced the hiring of Danielle Snow as Chief Operating Officer and Matteo Zanella as Vice President of Product.

“FORM has experienced tremendous growth in the past year - expanding our commercial offerings, more than doubling the size of our team, and greatly increasing our patient population - and it is essential that we have thoughtful, strategic leaders in place to continue setting a high standard in obesity medicine,” said Evan Richardson, founder and CEO of FORM. “The addition of Danielle Snow and Matteo Zanella reflects our commitment to delivering the highest quality clinical obesity care to as many people as possible. I look forward to working with these extraordinary leaders.”

Danielle Snow has 25 years of experience advising high-growth startups through IPOs, mergers, and acquisitions. She most recently spent a decade at Included Health (formerly Grand Rounds), where she served in several leadership positions, including Senior Vice President and Chief of Staff. At Included Health, she was responsible for ensuring the clinical and operating teams delivered quality patient care and she grew the team from zero to over 1000 employees working at multiple sites and remote. Danielle began her career at TiVo and later held positions at VUDU and Reputiation.com. She’s also advised numerous other businesses throughout her career.

Matteo Zanella joins FORM with over 20 years of experience managing product, design, engineering, product marketing, and strategy for companies ranging from small startups to Fortune 50 brands to international nonprofits. Matteo most recently served as VP of Product Management, Design, & Engineering at Sana which helps small businesses provide high-quality health plans. He previously was Senior Director of Product, Virtual Care & Navigation at Rally Health, and Director of Product, Member Experience & Platform at Collective Health. He also held various roles at Facebook, The Boston Consulting Group, and Hewlett Packard Enterprise.

FORM recently announced the launch of FORMFitTM, a program helping employers expand access to high-quality, clinical obesity care while managing costs. Employers looking to control cost can leverage FORMfit to manage GLP-1s while also providing a high-impact obesity solution that utilizes lower-cost medications or no medication as appropriate. Employers ready to invest in GLP-1s can offer employees comprehensive wrap-around clinical care from FORM that maximizes weight loss results and their ROI. FORMfit allows employers to ensure that all employees with obesity have access to best-in-class, specialized clinical care rather than cutting off access due to budgetary constraints.

Last month, FORM announced it had expanded its commercial leadership team.

About FORM

FORM is the virtual obesity medicine clinic empowering patients with obesity to take control of their health. Founded in 2019, FORM provides each patient with a clinical Care Team consisting of a dedicated board-certified Doctor and a Registered Dietitian who develop a personalized weight loss plan that includes lifestyle counseling that addresses nutrition, physical activity, and mindset shifts, along with a prescription for FDA-approved weight loss medication, if appropriate. Patients use the FORM app to meet with their Care Team for frequent video visits, message their Team between visits, track weight, and engage in educational resources. FORM is covered by most major insurance plans, including Medicare. Learn more at https://www.formhealth.co/.

Contacts

FORM


Release Versions

Contacts

More News From FORM

Form Health Simplifies GLP-1 Coverage Opportunities for Employers with Transparent, Predictable Pricing

BOSTON--(BUSINESS WIRE)--Today, Form Health, the national leader in science-based obesity and cardiometabolic care, announced access to new programs that provide employers with transparent, predictable access to obesity management medications from Eli Lilly and Company (Lilly) and Novo Nordisk (Novo), helping organizations offer comprehensive, wraparound care while controlling costs. This builds on Form’s work with both companies. Form was one of the first telemedicine obesity care providers in...

Form Health Selected for Novo Nordisk’s NovoCare® Platform to Expand Access to Science-Based Obesity Care Across the United States

BOSTON--(BUSINESS WIRE)--Today, Form Health, the leading provider of science-based obesity and cardiometabolic care in the United States, announced its selection as a healthcare provider option on Novo Nordisk’s NovoCare® platform. NovoCare® connects patients seeking treatment for chronic care with trusted healthcare providers, and Form Health’s inclusion will expand access to high-quality, evidence-based care delivered by trained Obesity Medicine Clinicians and Registered Dietitians. The relat...

Form Health, the National Leader in Science-Based Total Weight and Cardiometabolic Care, Named a “Fierce 15” Company of 2025

BOSTON--(BUSINESS WIRE)--Form Health, the leading provider of science-based total weight and cardiometabolic care in the United States, today announced that Fierce Healthcare has named it as one of 2025’s “Fierce 15” healthcare companies. The annual special report features the most innovative private healthcare companies looking to change the face of the industry. “The entire Form Health team is thrilled to be named a Fierce 15 Company of 2025 and grateful to Fierce Healthcare for this honor,”...
Back to Newsroom